8:32 am Idera Pharma announces agreement with Abbott (ABT) to develop a companion diagnostic for imo-8400 in genetically defined forms of b-cell lymphoma
View todays social media effects on IDRA
View the latest stocks trending across Twitter. Click to view dashboard
See who Idera is hiring next, click here to view
